This text-based CME activity explores the role of muscarinic receptor modulation in the treatment of schizophrenia. Learners will gain insights into the mechanism of action, comparative efficacy, and safety profile of xanomeline-trospium as an alternative to D2 antagonists. Dosing strategies, titration protocols, and the management of cholinergic side effects are reviewed to support real-world application. Practical approaches to patient selection, cross-titration, and monitoring during initiation are highlighted to facilitate individualized care and improve treatment adherence.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Free Registration | Free |
| Tufts-Affiliated HCP - Early Bird (by 10/5/26) | $75 |
| Tufts-Affiliated HCP - Standard | $175 |
| Trainees & Allied Health - Early Bird (by 10/5/26) | $75 |
| Trainees & Allied Health - Standard | $175 |
| Physicians - Early Bird (by 10/5/26) | $150 |
+3 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Pediatrics
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Neurology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Article / monograph / reference
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedNov 21, 2025
-
Last day to claim creditNov 22, 2026 6 weeks left
-
Global Learning Collaborative Chairperson s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice Overcoming Clinical Inertia
-
Global Learning Collaborative Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
-
Global Learning Collaborative From Inertia to Action: Integrating Muscarinic Therapies into Schizophrenia Practice
-
Clinical Care Options, LLC (dba Decera Clinical Education) Redefining Schizophrenia Care: Exploring Novel Mechanisms and Clinical Applications
-
Neuroscience Education Institute +1 Of Musc and Men: The Exciting Potential of Muscarinic Receptor Modulation in the Treatment of Schizophrenia
-
American Psychiatric Association Anticholinergics: The Good, The Bad, and The Ugly
